Loading company…
MIRAE CELL BIO develops stem cell therapies for conditions in urology, neurology, and autoimmune disease.
MIRAE CELL BIO develops cell therapies using pluripotent embryonic stem cells, with a focus on urology, neurology, and autoimmune diseases. Its MMSC therapies are being developed for conditions including interstitial cystitis and underactive bladder. Founded in 2006, the company is based in Seoul, South Korea.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in